- Investigator
- Mehdi S Mirsaeidi
- Ages
- 18 Years - 75 Years
- Sexes
- All
Clinical trials
-
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis -
SUNRAY-02 - Investigator
- Pablo R P Santana
- Ages
- 18 Years - N/A
- Sexes
- All